ZymoGenetics plans to sell a parcel of vacant land near its Seattle headquarters.
ZymoGenetics wants to turn some of its land into cash before the end of the year.
The Seattle biotechnology company said in a regulatory filing that it wants to sell a vacant lot near its Eastlake headquarters.
The traransaction is “still in negotiation, not settled,” said spokeswoman Susan Specht on Wednesday, but a sale would “a nice chunk of change.”
The land, previously tagged for future expansion, has a carrying cost of $4.5 million, according to a filing with the Securities and Exchange Commission.
Most Read Business Stories
It’s not the first time that ZymoGenetics sheds real estate. In 2002, the company sold its state-of-the-art headquarters for $52 million, and it now leases the building, a historic power plant near Lake Union.
“We’re not in the real estate business,” said Specht. Selling the lot is a way to “monetize our assets in the best interest of shareholders.”
Ángel González: 206-515-5644 or agonzalez@seattletimes.com